Rhabdomyosarcoma staging: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 11: | Line 11: | ||
! style="background: #4682B4; color:#FFF;" | Description | ! style="background: #4682B4; color:#FFF;" | Description | ||
|- | |- | ||
| style="padding: 5px 5px; background: # | | style="padding: 5px 5px; background: #B8B8B8;" | Stage 1 | ||
| style="padding: 5px 5px; background: # | | style="padding: 5px 5px; background: #B8B8B8;" | Favorable site- orbit, eyelid, head and neck (excluding parameningeal), genitourinary (non-bladder, non-prostate); N0 or N1; M0 | ||
|- | |- | ||
| style="padding: 5px 5px; background: # | | style="padding: 5px 5px; background: #B8B8B8;" | stage 2 | ||
| style="padding: 5px 5px; background: # | | style="padding: 5px 5px; background: #B8B8B8;" | Unfavorable site- urinary bladder, prostate, extremity, trunk, parameningeal, other; size <5 cm; N0; M0 | ||
|- | |- | ||
| style="padding: 5px 5px; background: # | | style="padding: 5px 5px; background: #B8B8B8;" | stage 3 | ||
| style="padding: 5px 5px; background: # | | style="padding: 5px 5px; background: #B8B8B8;" | Unfavorable site- Bladder, prostate, extremity, trunk, parameningeal, other; size <5 cm; N1; M0 | ||
|- | |- | ||
| style="padding: 5px 5px; background: # | | style="padding: 5px 5px; background: #B8B8B8;" | stage 3 | ||
| style="padding: 5px 5px; background: # | | style="padding: 5px 5px; background: #B8B8B8;" | Unfavorable site- Bladder, prostate, extremity, trunk, parameningeal, other; size >5 cm; N0 or N1; M0 | ||
|- | |- | ||
| style="padding: 5px 5px; background: # | | style="padding: 5px 5px; background: #B8B8B8;" | stage 4 | ||
| style="padding: 5px 5px; background: # | | style="padding: 5px 5px; background: #B8B8B8;" | Favorable or unfavorable site- N0 or N1 ; M1 | ||
|} | |} | ||
<sup>N0 = Regional nodes not clinically involved; | <sup>N0 = Regional nodes not clinically involved; | ||
| Line 30: | Line 30: | ||
M0 = No metastasis; | M0 = No metastasis; | ||
M1 = distant metastasis</sup> | M1 = distant metastasis</sup> | ||
==References== | ==References== | ||
Revision as of 21:17, 3 September 2015
|
Rhabdomyosarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Rhabdomyosarcoma staging On the Web |
|
American Roentgen Ray Society Images of Rhabdomyosarcoma staging |
|
Risk calculators and risk factors for Rhabdomyosarcoma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Staging of rhabdomyosarcoma
According to the childrens oncology group, there are four stages of rhabdomyosarcoma based on the location of tumor, size of tumor, involvement of lymph nodes, and metastasis. The stages of rhabdomyosarcoma are shown in the table below:
| Stage | Description |
|---|---|
| Stage 1 | Favorable site- orbit, eyelid, head and neck (excluding parameningeal), genitourinary (non-bladder, non-prostate); N0 or N1; M0 |
| stage 2 | Unfavorable site- urinary bladder, prostate, extremity, trunk, parameningeal, other; size <5 cm; N0; M0 |
| stage 3 | Unfavorable site- Bladder, prostate, extremity, trunk, parameningeal, other; size <5 cm; N1; M0 |
| stage 3 | Unfavorable site- Bladder, prostate, extremity, trunk, parameningeal, other; size >5 cm; N0 or N1; M0 |
| stage 4 | Favorable or unfavorable site- N0 or N1 ; M1 |
N0 = Regional nodes not clinically involved; N1 = Regional nodes clinically involved; M0 = No metastasis; M1 = distant metastasis